Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recent developments of RNA-based vaccines in cancer immunotherapy.
Faghfuri E, Pourfarzi F, Faghfouri AH, Abdoli Shadbad M, Hajiasgharzadeh K, Baradaran B. Faghfuri E, et al. Expert Opin Biol Ther. 2021 Feb;21(2):201-218. doi: 10.1080/14712598.2020.1815704. Epub 2020 Sep 3. Expert Opin Biol Ther. 2021. PMID: 32842798 Review.
Invited letter to editor in response to profiling inflammatory cytokines following zinc supplementation: a systematic review and meta-analysis of randomised controlled trials.
Faghfouri AH, Baradaran B, Khabbazi A, Khaje Bishak Y, Zarezadeh M, Tavakoli-Rouzbehani OM, Faghfuri E, Payahoo L, Alipour M, Alipour B. Faghfouri AH, et al. Among authors: faghfuri e. Br J Nutr. 2022 Feb 14;127(3):479-480. doi: 10.1017/S0007114521001070. Epub 2021 Mar 25. Br J Nutr. 2022. PMID: 33762049 No abstract available.
PPAR-gamma agonists: Potential modulators of autophagy in obesity.
Faghfouri AH, Khajebishak Y, Payahoo L, Faghfuri E, Alivand M. Faghfouri AH, et al. Among authors: faghfuri e. Eur J Pharmacol. 2021 Dec 5;912:174562. doi: 10.1016/j.ejphar.2021.174562. Epub 2021 Oct 13. Eur J Pharmacol. 2021. PMID: 34655597 Review.
Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial.
Faghfouri AH, Baradaran B, Khabbazi A, Abdoli Shadbad M, Papi S, Faghfuri E, Khajebishak Y, Rahmani S, Tolou Hayat P, Alipour B. Faghfouri AH, et al. Among authors: faghfuri e. Int Immunopharmacol. 2022 Aug;109:108825. doi: 10.1016/j.intimp.2022.108825. Epub 2022 May 10. Int Immunopharmacol. 2022. PMID: 35561480 Clinical Trial.
22 results